Clinical Trial: Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Toxic Epidermal Necrolysis
Study Type: INTERVENTIONAL
Official Title: Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis: a Single-arm, Open, Single-center Study
Brief Summary:
To evaluate the efficacy and safety of methylprednisolone combined with the JAK inhibitor abxitinib in the treatment of toxic epidermal necrolysis
Read more